Transgender hormone therapy (female-to-male) to individuals taking bioidentical hormones in the form of testosterone (including esters) and do not apply to those taking synthetic AAS (e.g., nandrolone) or dihydrotestosterone. Transgender hormone therapy (female-to-male) Transgender hormone therapy of the female-to-male (FTM) type, also known as masculinizing hormone therapy, is a form of hormone therapy and sex reassignment therapy which is used to change the secondary sexual characteristics of transgender people from feminine (or androgynous) to masculine. It is one of two types of transgender hormone therapy (the other being male-to-female), and is predominantly used to treat transgender men and other transmasculine individuals. Some intersex people
Human male sexuality community. Human male sexuality Human male sexuality covers physiological, psychological, social, cultural, and political aspects of the human male sexual response and related phenomena. It encompasses a broad range of topics involving male sexual desires and behavior that have also been addressed by ethics, morality, and religion. There are a number of factors that influence male sexuality and sexual behaviour, including expected parental investment, and paternal presence during development. Elizabeth Cashdan proposed that mate strategies among both genders differ depending on how much parental investment is expected of the male, and provided research support for her hypotheses. When men expect